Allergan plots 117 job cuts in the wake of Kythera buyout

Tracy Staton

The job-cutting ax has been hovering over Biopharmaceuticals ever since agreed to buy the company in April. Now, that ax is getting ready to fall.

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS